Olefins and polyolefins producer Borealis has signed an agreement to acquire Integra Plastics, a Bulgarian advanced mechanical recycling company. Closing of the transaction, for which no financial details were disclosed, is subject to customary regulatory approvals.
On Monday, UK Prime Minister Rishi Sunak announced £29.5 billion ($36.8 billion) of private sector investment in Britain at a gathering of global executives intended to showcase Britain’s appeal to global investors.
Novo Nordisk wants to make another major capital investment in production capacity for its diabetes and obesity therapies. The Danish drugmaker announced to spend more than 16 billion Danish kroner (€2.1 billion euros) starting in 2023 to expand its production site in Chartres, France, adding aseptic production and finished production processes and an extension of the current Quality Control Laboratory.
EuroAPI has completed the acquisition of BianoGMP, a contract development and manufacturing organization (CDMO) specializing in oligonucleotides.
Major French oil company TotalEnergies SE and Saudi Basic Industries Corp. (SABIC) are considering selling a jumbo US plant that produces styrene and polystyrene, used in products such as plastic packaging, disposable cups, and insulation.
Merck & Co. (MSD) and Caraway Therapeutics announced that the companies have agreed Merck & Co., through a subsidiary, will acquire Caraway Therapeutics for a total potential consideration of up to €557 million ($610 million), including an undisclosed upfront payment and contingent milestone payments.
Ineos Styrolution, a styrenics producer, has opened a new world-scale ABS (acrylonitrile butadiene styrene) facility located in Ningbo, China, together with its joint venture partner Sinopec. The facility has an annual nameplate capacity of 600,000 tons.
Orion opens its first greenfield project – a carbon black plant in eastern China that will supply fast-growing demand in Asia.
AGC Wakasa Chemicals, part of Japanese group AGC, has completed a new large-scale production line at its Kaminaka Plant in Fukui prefecture, Japan, as it expects demand for agrochemicals and pharmaceuticals to grow steadily against a backdrop of population growth and improvement of living standards.
The European Chemical Industry Council, CEFIC, announced 26 companies and national associations as the key initiatives featured in the 2023 European Responsible Care Awards Gallery.
German chemicals and ingredients distributor Brenntag has opened its new facility in Maurice, Louisiana, USA. Strategically positioned along the US Gulf Coast, the new site will be the primary operations hub for Coastal Chemical, a subsidiary of Brenntag, in addition to serving other areas in the region, the company said.
AkzoNobel is investing €32 million in a new plant at its Vilafranca site in Spain, which will produce bisphenol-free coatings for the metal packaging industry in Europe, Middle East and Africa (EMEA). AkzoNobel expects facility to be operational by mid-2025 and to create around 40 jobs.
The $5 trillion chemical industry plays a pivotal role in the global economy, serving as the foundation for countless sectors from paints to plastics that rely on its products and processes. With a rich history of innovation, chemical companies are well-positioned to lead the charge on decarbonization.
French industrial gases group Air Liquide and Japanese energy company Eneos have signed a memorandum of understanding (MoU) to collaborate on accelerating the development of low-carbon hydrogen in Japan and contribute to the energy transition, covering the entire low-carbon hydrogen value chain.
OCI Global, the world’s third largest nitrogen fertilizer and ammonia producer, is supplying Röhm, a leading manufacturer of methacrylates, with bio-ammonia for the production of methyl methacrylate (MMA), an important precursor for Plexiglas.
German chemicals, pharmaceuticals and life sciences group Merck, which operates its Healthcare business as EMD Serono in the US and Canada, announced that it plans to move its US Healthcare headquarters, currently located in Rockland, Massachusetts, to Boston’s Seaport district.
Sweden’s Hexpol has acquired the American thermoplastic elastomers (TPE) compounder Star Thermoplastic Alloys and Rubbers for $26.5 million from Thomas A. Dieschbourg, who founded the company in 1993 and will remain as its president.
Fujifilm Diosynth Biotechnologies unveiled its new $2 billion large-scale cell culture manufacturing facility in Holly Springs, North Carolina, US.
Evonik announced that it is significantly expanding its commitment to developing solutions for the circular economy, bundling its activities in the group-wide Circular Economy Program. From 2030, the German specialty chemicals company aims to generate at least €1 billion in additional sales per year from circular products and technologies.
The Croatian start-up Makabi has created a 3-in-1 encapsulation technology for plant protection and nutrition and controlled release of bioactive components.
Yara has decided to divest its fertilizer import and distribution subsidiary in Ivory Coast. The move follows a thorough analysis of the company’s operations, considering market dynamics, regulatory environment, and strategic growth opportunities.
Danish drugmaker Novo Nordisk plans to invest more than 42 billion Danish kroner (about €5.6 billion) starting in 2023 to expand existing manufacturing facilities at the company’s Kalundborg, Denmark, site to meet future market demands.
Azelis has agreed to acquire 100% of the shares of Agspec Australia, a leading distributor of crop nutrition, crop protection and specialty agricultural products in Australia. Financial terms of the transaction, which is expected to close in the first quarter of 2024 and is subject to customary closing conditions, were not disclosed.
Olon, an Italian CDMO and API producer of active pharmaceutical ingredients (APIs), plans to invest €10 million in a multi-year expansion of its production site in Mahad, India.
Arkema board of directors has unanimously expressed its confidence in the company’s chairman and CEO Thierry Le Hénaff to execute the strategy announced during Arkema’s capital markets day on Sep. 27 and proposed the renewal of his term of office for four years at the company’s next annual shareholders meeting in May 2024.
Serbian agrochemicals producer Elixir Group and German minerals producer K+S have signed a cooperation agreement for the production and distribution of crystalline water-soluble fertilizer mono-ammonium phosphate (MAP).
According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a major revision of pharmaceutical regulations as proposed by the European Commission in April this year could shrink Europe's share of global research and development by a third to 21% by 2040, resulting in a loss of investment of €2 billion ($2.15 billion) a year.
Air Products unveiled plans for a carbon capture facility at its Rotterdam plant, intending to generate "blue" hydrogen for ExxonMobil's refinery and other clients. Anticipated to become Europe's largest upon its scheduled completion in 2026, this initiative will play a pivotal role in substantially reducing carbon dioxide emissions in Rotterdam, aligning with the Dutch climate objectives.
Noramco, a US producer of active pharmaceutical ingredients (APIs), has completed the acquisition of the Cambrex drug product business unit previously known as Halo Pharmaceuticals. Financial details were not disclosed.
DKSH has signed an agreement to acquire 100% of Bio-Strategy, said to be the largest independent distributor of scientific instruments in Australia and New Zealand, with a focus primarily on life sciences, medical & healthcare and environment & agriculture.
US specialty chemical company Milliken is rebranding its healthcare business Milliken Healthcare Products to Ovik Health.
US specialty chemicals producer Ashland has announced that it will start a divestiture process for the company’s nutraceuticals business.
Solvay announced the future executive leadership team, effective upon completion of the planned separation of Solvay into two companies – Solvay and Syensqo – which is expected to be completed in December.
DMC Biotechnologies announced a new 880 square meter (9,500 square foot) metabolic engineering and fermentation facility in North Carolina, to support a team of scientists advancing DMC products and active collaborations.
Anglo-Swedish drugmaker AstraZeneca entered into a collaboration and investment agreement with Cellectis, a French clinical-stage biotechnology company, to accelerate the development of therapeutics across oncology, immunology and rare diseases.
